HJB - Your Trusted Biologics CDMO Partner

HJB, CDMO, biologics, HJB Bio, hjbbio, China CDMO, 杭州奕安济世, Just Bio, Just biotherapeutics, HJB bio, HJB China, Hangzhou HJB

HJB - Your Trusted Biologics CDMO Partner

EN / CN
CASE STUDY

Significantly Improve Productivity on A Technology Transferred FB Process

Background

A technology transfer case which significantly improved productivity using HJB upstream process development platform. The original FB process was transferred from a well-known global company.


Result

HJB is capable to rapidly increased FB productivity by 3.7X compared to the original FB process using the original production cell line with very limited process information provided by the original company. As the result, process change IND filing and approval was speedy and successful in China. In addition, we rapidly developed IFB and CP process, which improved productivity to 6.6X and 37.7X compared to original FB process respectively.

USP-case 1.1.png


              

CASE STUDY